A Phase I Study of the P-Glycoprotein Antagonist Tariquidar in Combination with Vinorelbine

Abstract

Tariquidar is a potent Pgp antagonist, without significant side effects and much less pharmacokinetic interaction than previous Pgp antagonists. Tariquidar offers the potential to increase drug exposure in drug-resistant cancers.